Guide-free Cas9 from pathogenic Campylobacter jejuni bacteria causes severe damage to DNA.
Chinmoy SahaPrarthana MohanrajuAndrew Peter StubbsGaurav DugarYouri HoogstrateGert-Jan KremersWiggert A van CappellenDeborah Horst-KreftCharlie LaffeberJoyce H G LebbinkSerena BruensDuncan GaskinDior BeerensMaarten KlunderRob JoostenJeroen A A DemmersDik C van GentJohan W MoutonPeter J van der SpekJohn van der OostPeter van BaarlenRogier LouwenPublished in: Science advances (2020)
CRISPR-Cas9 systems are enriched in human pathogenic bacteria and have been linked to cytotoxicity by an unknown mechanism. Here, we show that upon infection of human cells, Campylobacter jejuni secretes its Cas9 (CjeCas9) nuclease into their cytoplasm. Next, a native nuclear localization signal enables CjeCas9 nuclear entry, where it catalyzes metal-dependent nonspecific DNA cleavage leading to cell death. Compared to CjeCas9, native Cas9 of Streptococcus pyogenes (SpyCas9) is more suitable for guide-dependent editing. However, in human cells, native SpyCas9 may still cause some DNA damage, most likely because of its ssDNA cleavage activity. This side effect can be completely prevented by saturation of SpyCas9 with an appropriate guide RNA, which is only partially effective for CjeCas9. We conclude that CjeCas9 plays an active role in attacking human cells rather than in viral defense. Moreover, these unique catalytic features may therefore make CjeCas9 less suitable for genome editing applications.
Keyphrases
- crispr cas
- genome editing
- dna damage
- biofilm formation
- cell death
- circulating tumor
- dna binding
- oxidative stress
- cell free
- endothelial cells
- single molecule
- nucleic acid
- antimicrobial resistance
- sars cov
- pseudomonas aeruginosa
- staphylococcus aureus
- early onset
- dna repair
- candida albicans
- escherichia coli
- cell proliferation
- circulating tumor cells
- cystic fibrosis